Andrew Gane profile page

Andrew is responsible for building the innovation pipeline in collaboration with the R&D and commercial teams. His knowledge and understanding of emerging trends and new applications have been fundamental to developing the product portfolio into workflow-based solutions, with a particular focus on next-generation sequencing (NGS). Andrew has more than 30 years of experience in immunodiagnostics and molecular diagnostics in both lab-based and product development roles.